Skip to main content
Premium Trial:

Request an Annual Quote

GE Healthcare, GlaxoSmithKline, IBM, Max Planck, StoreAge Networking Technologies

Premium

GE Healthcare to Relocate Imaging Research

GE Healthcare will relocate Imaging Research, the Ontario-based bioinformatics and screening company it acquired with Amersham, to Piscataway, NJ, later this month, according to BioInform’s sister publication GenomeWeb News

The company, which employed 45 staffers as of December 2003, will formally shut down its St. Catharines, Ontario, facility before the end of March, according to people familiar with the event. Amersham acquired Imaging Research in 2003, and GE Healthcare bought Amersham one year later.

Imaging Research’s products and services include laboratory-imaging systems and gene expression-analysis software, such as its ArrayVision software for the quantifying gene-expression arrays, and ArrayStat, which analyzes expression array data.

The company also sells ultra-high throughput screening platforms, such as LEADseeker, and the IN Cell Analyzer 1000 automated cell-screening system.


Glaxo to Use Partek 6.0

Partek has licensed its Partek 6.0 data-mining software to the GlaxoSmithKline cheminformatics department in Research Triangle Park, NC, the company said last week.

Financial details of the deal were not disclosed.


IBM Offers Blue Gene on Tap

IBM will offer on-demand access to a Blue Gene supercomputer housed at a new Deep Computing Capacity on Demand Center in Rochester, MN.

IBM customers will be able to remotely access up to 5.7 teraflops of peak performance through the Blue Gene system via a secure virtual private network and pay only for the amount of capacity reserved, the company said.

The company said the service should be attractive to “customers in market segments that have traditionally not been able to effectively access a supercomputer at a price within their budgets.”

Pricing details for the on-demand service were not provided.


Max Planck to Use DNAStar Software

Germany’s Max Planck Society has signed a “broad” license agreement for DNAStar’s bioinformatics software, according to the company’s European distributor, GATC Biotech.

The Max Planck Society purchased a site license for DNAStar’s Lasergene 6, StarBlast, and GenVision packages.

The agreement will provide access to the software and technical support to all research departments of the Max Planck Institutes.


Zurich Genomics Center Opts for StoreAge SAN

Storage-area-network provider StoreAge Networking Technologies said last week that the Functional Genomics Center Zurich (FGCZ) is using its StoreAge SVM (Storage Virtualization Manager) SAN storage management system.

The deployment was led by ABC Systems, StoreAge’s distributor in Switzerland.

FGCZ’s SAN now includes IBM xSeries file, database, and backup servers in a Microsoft Windows environment and different classes of storage systems.

Financial terms of the agreement were not provided.

 

Filed under

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.